Literature citations
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
Cossins J.; Belaya K.; Hicks D.; Salih M.A.; Finlayson S.; Carboni N.; Liu W.W.; Maxwell S.; Zoltowska K.; Farsani G.T.; Laval S.; Seidhamed M.Z.; Donnelly P.; Bentley D.; McGowan S.J.; Muller J.; Palace J.; Lochmuller H.; Beeson D.; Donnelly P.; Bell J.; Bentley D.; McVean G.; Ratcfliffe P.; Taylor J.; Wilkie A.; Donnelly P.; Broxholme J.; Buck D.; Cazier J.B.; Cornall R.; Gregory L.; Knight J.; Lunter G.; McVean G.; Taylor J.; Tomlinson I.; Wilkie A.; Buck D.; Allan C.; Attar M.; Green A.; Gregory L.; Humphray S.; Kingsbury Z.; Lamble S.; Lonie L.; Pagnamenta A.; Piazza P.; Polanco G.; Trebes A.; McVean G.; Donnelly P.; Cazier J.B.; Broxholme J.; Copley R.; Fiddy S.; Grocock R.; Hatton E.; Holmes C.; Hughes L.; Humburg P.; Kanapin A.; Lise S.; Lunter G.; Martin H.; Murray L.; McCarthy D.; Rimmer A.; Sahgal N.; Wright B.; Yau C.;
Brain 136:944-956(2013)
Cited for: INVOLVEMENT IN CMS14; VARIANT CMS14 GLY-68; CHARACTERIZATION OF VARIANT CMS14 GLY-68;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.